Hepatic porphyrias and alcohol;Hepatische porphyrien und alkohol

Medizinische Klinik

Volumn 94, Issue 6, 1999, Pages 314-328

  Doss, Manfred O ^a   Kühnel, Alexandra ^b   Groß, Ulrich ^b   Sieg, Ina ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

Acute and chronic hepatic porphyrias; Alcohol; Diagnosis; Heme biosynthesis; Secondary coproporphyrinuria; Therapy

Indexed keywords

ALCOHOL; COPROPORPHYRINOGEN OXIDASE; HEME; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

ACUTE INTERMITTENT PORPHYRIA; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; FATTY LIVER; HEME SYNTHESIS; HEPATIC PORPHYRIA; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; PORPHYRIA CUTANEA TARDA; PORPHYRIN METABOLISM; REVIEW; URINALYSIS;

EID: 0345120743     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044890     Document Type: Review

References (116)

1. Abdulla M, Haeger-Aronsen B, Sevensson S. Effect of ethanol and zinc on ALA-dehydratase activity in red blood cells. Enzyme 1976;21:248-52.
2. Aubin HJ, Laureanx C, Tilikete S, et al. How useful is aminolevulinic acid dehydratase as a marker of recent alcohol intake. Add Biol 1997;2:225-8.
3. Beattie DS, Patton GM, Rubin E. The control of δ-aminolevulinic acid synthase in rat liver mitochondria. Effect of pyrazole on the apparent "induction". Enzym 1973;16:232-7.
4. Blauvelt A. Hepatitis C virus and human innmmodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 1996;132:1303-4.
5. Bloomer JR, Rank JM, Payne WD, et al. Follow-up after liver transplantation for protoporphyric liver disease. Liv Transpl Sur 1996;4:269-75.
6. Bloomer JR, Weimer MK, Bossenmaier IC, et al. Liver transplantantation in a patient with protoporphyria. Gastroenterology 1989;97:188-94.
7. Bonkowsky HL, Healy JF, Sinclair PK, et al. Iron and the liver: acute effects of iron-loading on hepatic heme synthesis of rats. J Clin Invest 1983;71:1175-82.
8. Brugsch JT. Toxic porphyrinuria following chronic alcoholism. Proc Staff Meet Mayo Clin 1937;12:609-13.
9. Cacheux V, Martasek P, Fougerousse F, et al. Localization of the human coproporphyrinogen oxidase gene to chromosome band 3q12. Hum Genet 1994;94:557-9.
10. Day RS, Eales L, Meissner D. Coexistent variegate porphyria and porphyria cutanea tarda. N Engl J Med 1982;307:36-41.
11. Deybach J-Ch, Puy H, Robréau A-M, et al. Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria. Hum Mol Genet 1996; 5:407-10.
12. Doss M. Alkoholbedingte Störungen des Porphyrinstoffwechsels. Leber Magen Darm 1978;8:278-85.
13. Doss M. Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humans. Klim Wochenschr 1980;58:141-8.
14. Doss M. Hepatic porphynas: Pathobiochemical, diagnostic, and therapeutic implications. In: Popper H, Schaffner F, eds. Progress in liver diseases. New York: Grune & Stratton, 1982:573-97.
15. 5. Doss MO. Alcohol and porphyrin metabolism. In: Seitz HK, Kommerell B, eds. Alcohol related disease in gastroenterology, Berlin-New York: Springer, 1985: 232-52.
16. Doss MO. Porphyrinurias and occupational disease. Ann NY Acad Sci 1987;514:204-18.
17. Doss M. New dual form of porphyria. Lancet 1988;23:945-6.
18. Doss MO. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda. Eur J Clin Invest 1989;19:20-5.
19. Doss MO. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxyhse deficiencies. Clin Genet 1989;35:146-51.
20. Doss MO. Diagnose und Therapie hepatischer Porphyrien. Acta Med Aust 1990;5:94-9.
21. Doss MO. Krankheiten und Störungen der Porphyrinund Hämbiosynthese. In: Gross R, Schölmerich P, Gerok W, Hrsg. Die Innere Medizin, 9. Aufl. Stuttgart-New York: Schattauer, 1996:1002-15.
22. Doss MO. Hepatische Porphyrien. Med Klin 1997;92: 745-6.
23. Doss M. Baumann H, Sixel F. Alcohol in acute porphyria. Lancet 1982;2:1307.
24. Doss M, Benkmann HG, Goedde HW. δ-aminolevulinic acid dehydrase (porphobilinogen synthase) in two families with inherited enzyme deficiency. Clin Genet 1986;30:191-8.
25. Doss M, Frank M. Hepatobiliary implications in protoporphyria, a 20-year study.Clin Biochem 1989;22:223-9.
26. Doss MO, Frank M, Braun-Falco O. Porphyria cutanea tarda: erythrocyte decarboxylase activity in 471 consecutive patients. Curr Probl Dermatol 1991;20:97-105.
27. Doss MO, Honcamp M, Frank M. Arzneistoffe bei akuten hepatischen Porphyrien und Empfehlungen zur Anästhesie. In: Rote Liste 1997. Aulendorf: E. Cantor, 1997:479-80.
28. Doss M, Look D, Henning H, et al. Hepatic porphyrins and urinary porphyrins and porphyrin precursors in liver cirrhosis. Klin Wochenschr 1972;50:1025-32.
29. Doss MO, Nawrocki P, Schmidt A, et al. Einfluß von Diät, Glycin und Alkohol auf die Porphyrinurie bei chronischer hepatischer Porphyrie. Dtsch Med Wochenschr 1971;96:1229-31.
30. Doss MO, Sassa S. The porphyrias. In: Noe DA, Rock RC, eds. Laboratory medicine. The selection and interpretation of clinical laboratory studies. Baltimore: Williams & Wilkms, 1994:535-53.
31. Doss M, Sauer H, von Tiepermann R, et al. Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin. Im J Biochem 1984;4:369-73.
32. Doss MO, Sieg I. Alkohol und Porphyrinstoffwechsel. In: Seitz HK, Lieber CS, Simanowski UA, Hrsg. Handbuch Alkohol, Alkoholismus, alkoholbedingte Organschäden. Leipzig-Heidelberg: J. A. Barth, 1995: 167-89.
33. Doss M, von Tiepermann R, Stutz G, et al. Alcohol-induced decrease in uroporphyrinogen decarboxylase activity in nt liver and spleen. Enzyme 1981;26:24-31.
34. Elder GH, Roberts AG. Uroporphyrinogen Decarboxylase. J Bioenerg Biomembr 1995;27:207-212.
35. Felsher BF, Carpio NM, Englekmg DW, et al. Decreased hepatic uroporphyrinogen decarboxylase activity in porpliyria cutanea tarda. N Engl J Med 1982; 306:766-9.
36. Frank M, Doss MO. Schwere Leberkomplikationen bei Protoporphyne. Internist (Berlin) 1991;32:277-82.
37. Frank M, Doss MO. Diagnostische Porphyrinopathien bei hereditäreren Hyperbilirubinämien. Z Gastroenterol 1993;31:Suppl 2:111-3.
38. Frank M, Doss MO. Leberzirrhose bei Protoporphyrie: Gallensäurentherapie und Lebertransplantation. Z Gastroenterol 1995;33:399-403.
39. Franke K, Fikentscher R. Die Bedeutung der quantitativen Porphyrinbestimmung mit der Lumineszenzmessung für die Prüfung der Leberfunktion und für Ernährungsfragen. MMW 1935;2:171-2.
40. Fraser MB, Schacter BA. Increased bone marrow delta-aminolevulinic acid synthetase activity in the acute reversible sideroblastic anemia of alcoholics. Am J Hematol 1980;8:149-56.
41. Freesemann AG, Bhutani LK, Jacob K, et al. Interdependence between decree of porphynn excess and disease severity in congenital erythropoietic porphyria (Günter's disease). Arch Dermatol Res 1997;289: 272-6.
42. Freesemann AG, Doss MO. A new type of dual porphyria with uroporphyrinogen III synthase and decarboxylase deficiency with Günter's disease. Clin Lab 1997;43:667-72.
43. Freesemann A, Frank M, Sieg I, et al. Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver. Skin Pharmacol 1995;8:156-61.
44. Garey JR, Franklin KF, Brown DA, et al. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology 1993;105:165-9.
45. Garey JR, Harrison LM, Franklin KF, et al. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion ot exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest 1990;86:1416-22.
46. Gauer EB, Doss MO, Riemann JF. Erythrohepatische Protoporphyrie. Dtsch Med Wochenschr 1995; 120:713-7.
47. Goldberg A, McColl KEL, Moore MR. Alcohol and porphyria. Lancet 1981;2:905-6.
48. Grandchamp B, de Verneuil H, Beaumont C, et al. Tissue-specific expression of porphobilinogen deaminase: two isoenzymes from a single gene. Eur J Biochem 1987;162:105-10.
49. Grandchamp B, Lamoril J, Puy H. Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyna. J Bioenerg Biomem 1995; 27:215-9.
50. Groß U, Honcamp M, Doss MO. Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deammase activity in Germany. Eur J Clin Chem Clin Biochem 1996;34: 613-8.
51. Grover CA, Jasek MC, Frye GD. et al. Ethanol inhibition of reduced frequency-dependent rundown of calcium currents in acutely dissociated MS/nDB neurons from chronic in vivo lead-exposed adult rats. Neuro Toxicol 1997;18:179-90.
52. Hahn M, Bonkovsky HL. Multiple chemical sensitivity syndrome and porphyria. Arch Intern Med 1997; 157:281-5.
53. Hamlyn AN, Hopper J, Skillen AW. Assessment of erythrocyte δ-aminolevulinate dehydratase for outpatient detection of alcoholic liver disease: comparison with δ-glutamyltransferase and casual blood ethanol. Clin Chim Acta 1979;95:453-9.
54. Held H. Effect of alcohol on the heme and porphyrin synthesis interaction with phenobarbital and pyrazole. Digestion 1977;15:136-46.
55. Henriksson M, Timonen K, Mustajoki P, et al. Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients J Invest Dermatol 1996;106:346-50.
56. Hift R, Kirsch RE. Porphyria cutanea tarda. In: Hall P, ed. Alcoholic liver disease. London-Boston-Melbourne-Auckland: E. Arnold, 1995:219-28.
57. Ishida N, Fujita H, Fukuda Y, et al. Cloning and expression of the defective genes from a patient with δ-aminolevulinate dehydratase porphyria. J Clin Invest 1992;89:1431-7.
58. Jones RE, Chelsky M. Further discussion concerning porphyria cutanea tarda and TCDD exposure. Arch Environ Health 1986;41:100-3.
59. Kaplowitz N, Javitt N, Kappas A. Coproporphyrin I land III excretion in bile and urine. J Clin Invest 1972; 51:2895-9.
60. Kappas A, Sassa S, Galbraith A, et al. Theporphyrias. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease, 7th edn. New York: McGrawHill, 1995:2103-59.
61. Kauppinen R, Timonen K, Mustajoki P. Treatment of the porphyrias. Ann Med 1994;26:31-8.
62. Kodama T, Kondo M, Urata G, et al. Changes in aminolevutinate synthase and aminolevulinate dehydratase activity in cirrhotic liver. Gastroenterology 1983; 84:236-41.
63. Köstler E, Doss MO. Porphyria cutanea tarda (chronische hepatische Porphyrie). In: Ergebnisse der inneren Medizin und Kinderheilkunde, Bd. 61. Berlin-Heidelberg: Springer, 1993:124-70.
64. Köstler E, Doss MO. Porphyria cutanea tarda (chronische hepatische Porphyrie). Dtsch Med Wochenschr 1995; 120:1405-10.
65. Kondo M, Urata G, Shimizu Y. Decreased liver δ-aminolaevulinate dehydratese activity in porphyria cutanea tarda and in alcoholism. Clin Sci 1983;65:423-8.
66. Krasner N, Moore MR, Thompson GG, et al. Depression of erythrocyte δ-aminolaevulinate acid dehydratase activity in alcoholics. Clin Sci Mol Med 1974;46: 415-18.
67. Lamoril J, Deybach J-CH, Puy H, et al. Three novel mutations in the coproporphyrinogen oxidase gene. Hum Mut 1997;9:78-80.
68. Lane SE, Steward ME. Alcohol-mediated effects on the level of cytochrome P-450 and heme biosynthesis in cultured rat hepatocytes. Biochim Biophys Acta 1983;755:313-7.
69. Li F, Lim CK, Peters TJ Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in iron-overloaded and ethanol-treated rats. Biomed Chromatogr 1990;4:253-6.
70. Li F, Lim CK, Simpson KJ, Peters TJ. Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in human liver biopsies with special reference to alcoholic liver disease. J Hepatol 1989; 8:86-93.
71. Lindberg RLP, Porcher C, Grandchamp B, et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet 1996;12:195-99.
72. Lock G, Holstege A, Mueller AR, et al. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy. Liver 1996;16:211-17.
73. Martini GA. Klinik der Arzneimittelschädigung der Leber. Z Gastroenterol 1974;6:21-28.
74. Mazuner F, Moreau-Gaudry F, Salesse S, et al. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inher Mecab Dis 1997;20:247-57.
75. McColl KEL, Moore MR, Thompson GG, et al. Abnormal haem biosynthesis in chronic alcoholics. Eur J Clin Invest 1981;11:461-68.
76. McColl KEL, Thompson GG, Moore MR, et al. Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest 1980;10:107-12.
77. McColl KEL, Thompson GG, Moore MR, et al. Chester porphyria: biochemical studies of a new form of acute porphyria. Lancet 1985;2:796-99.
78. McEwin R. Porphyria in Australia. In: Doss M, ed. Porphyrins in human diseases, Proc I Int Porphyrin Meeting. Basel: Karger, 1976:233-44.
79. Mezey E. Ethanol metabolism and ethanol-drug interactions. Biochem Pharmacol 1976;25:869-75.
80. Moore MR. Biochemistry of porphyria. Int J Biochem 1993;25:1353-68.
81. Moore MR, Beattie AD, Thompson GG, et al. Depression of δ-aminolevulinic acid dehydratase activity by ethanol in man and rat. Clin Sci 1971;40:81-8.
82. Mukerji SK, Pimstone NR, Burns M. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology 1984;87:1248-54.
83. Mukerji SK, Saicheur T, Pimstone NR. Alcohol metabolism in liver disease may trigger clinical porphyria cutanea tarda because iron released from ferritin inhibits uroporphyrinogen decarboxylase activity and induces hepatic lipid peroxidation. Acta Haematol 1997;98:452.
84. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 1993;153:2004-8.
85. Nordmann Y, Amram D, Deybach JC, et al. Coexistent hereditary coproporphyria and congenital erythropoietic porphyria (Günther disease). J Inher Metab Dis 1990;13:687-91.
86. Ong PML, Lanyon WG, Graham G, et al. Acute intermittent porphyria: the in vitro expression of mutant hydroxymethylbilane synthase. Mol Cell Probes 1997;11: 293-6.
87. Orten JM, Doehr SA, Bond C, et al. Urinary excretion of porphyrins and porphyrin intermediates in human alcoholics. QJ Stud Alcohol 1963;24:598-609.
88. Polo CF, Afonson SG, Navone NM, et al. Zinc aminolevulinic acid dehydratase reactivation index as a tool for diagnosis of lead exposure. Ecotoxicol Environ Saf 1995;32:267-72.
89. Puy H, Robréau AM, Rosipal R, et al. Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in the human gene. Biochem Biophys Res Commun 1996;226:226-30.
90. Ratnaike S, Blake D. The diagnosis and follow-up of porphyria. Pathology 1995;27:142-53.
91. Robert TL, Varella L, Meguid MM. Nutrition management of acute intermittent porphyria. Nutrition 1994; 10:551-5.
92. Rubin E, Lieber CS. Ethanol metabolism in the liver. In: Popper H, Schaffner F, eds. Progress in liver diseases. New York: Grune & Stratton, 1972:549-66.
93. Salmon P. Hepatitis C virus infection and porphyria cutanea tarda in Australasia. Arch Dermatol 1996; 132:191.
94. Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994;343:1394-6.
95. Sassa S. Regulation of the genes for heme pathway enzymes in erythroid and non erythroid cells. Int J Cell Clon 1990;8:10-26.
96. Schoenfeld N, Mamet R, Leibovici L, et al. Alcohol-induced changes in urinary aminolevulinic acid and porphyrins: Unrelated to liver disease. Alcohol 1996;13:59-63.
97. Shanley BC, Zail SS, Joubert SM. Effect of ethanol on liver δ-aminolevulinate synthetase in rats. Lancet 1968; 1:70.
98. Shanley BC, Zail SS, Joubert SM. Effect of ethanol on liver δ-aminolevulinate synthase activity and urinary porphyrin excretion in symptomatic porphyria. Br J Haematol 1969;17:389-96.
99. Sieg I, Bhutani LK, Doss MO. Dual porphyria of coexisting variegata and cutanea tarda. Eur J Clin Chem Clin Biochem 1995;33:405-10.
100. Sieg I. Doss MO. HPLC der Koproporphyrin-I/III-Isomeren bei hepatischen Porphyrinopathien. Lab Med 1992;16:89-96.
101. Sieg I, Doss MO, Kandels H, et al. Effect of alcohol on δ-aminolevulinic acid dehydratase and porphyrin metabolism in man. Clin Chim Acta 1991;202:211-8.
102. Sixel-Dietrich F, Doss M. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication. Arch Dermatol Res 1985;278:13-16
103. Steinmüller T, Doss MO, Steffen R, et al. Lebertransplantation bei erythrohepatischer Protoporphyrie. Dtsch Med Wochenschr 1992;117:1097-102.
104. Stölzel U, Köstler E, Koszka C, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995;21:1 500-3.
105. Strik JJTWA. Doss M. Chronisch hepatische Porphyrie durch polyhalogenisierte aromatische Verbindungen bei Menschen. Therapiewoche 1978;28:8460-6.
106. Sturrock ED, Meissner PN, Maeder DL. et al. Uroporphyrinogen decarboxylase and protoporphyrinogen oxidase in dual porphyria. S Afr Med J 1989;76: 405-8.
107. Teschke R, Gorys-Könemann C, Daldrup T, et al. Influence of chronic alcohol consumption on hepatic heme and porphyrin metabolism. Biochem Pharmacol 1987;36:1133-8.
108. Thunell S, Floderus Y, Henrichson A, et al. Alcoholic beverages in acute porphyria. J Stud Alcohol 1992;3:272-6.
109. Topi GC, Amantea A, Griso D. Recovery from porphyria cutanea tarda with no specific therapy other than avoidance of hepatic toxins. Br J Derm 1984;111:75-82.
110. Von Tiepermann R, Koss G, Doss M. Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyna. Hoppe Seylers Z Physiol Chem 1980;361:1217-22.
111. Warnich L, Kotze MJ, Groenewald IM, et al. Identification of three mutations and associated haplotypes in the proroporphyrinogen oxidase gene in South African families with variegate porphyria. Hum Mol Genet 1996;5:981-4.
112. Watson CJ, Cardinal RA, Bossenmaier I, et al. Porphyria variegata and porphyna cutanea tarda in siblings: Chemical and genetic aspects. Proc Natl Acad Sci USA 1975;72:5126-9.
113. Wetterberg L. Report on an international survey of safe and unsafe drugs in acute intermittent porphyria. In: Doss M, Nawrocki P, eds. Porphyrins in human diseases - report of the discussions. Freiburg: Falk Foundation, 1976:191-202.
114. Wider EA, Ferranti D, Mozzarelli MN, et al. Modification of the levels of delta-aminolevulinic acid dehydratase in chronic alcoholic patients. Medicina 1997; 57:275-80.
115. Wissel PS, Sordillo P, Anderson KE, et al. Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Dermatol 1987;25:107-13.
116. Wright DJ, Lim CK, Peters TJ. High performance liquid Chromatographic studies of erythrocyte haem biosynthetic enzyme activities in alcoholic macrocytosis. Biomec Chromatogr 1990;4:249-52.